OFS Capital Corporation OFS Q1 2026 Earnings Massive EPS Beat Driven by Strong Net Investment Income Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline Tenable Holdings Q1 2026 Earnings Strong Profit Beat Amid Steady Cybersecurity Demand PDS Biotechnology Q1 2026 Earnings EPS Beat on Narrower Loss Clinical Progress in Focus ATYR Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Milestones Approach Nuburu Inc BURU Q3 2023 Earnings Net Loss Reported as Company Advances Industrial Laser Commercialization